Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and their active metabolites in plasma using UHPLC-MS/MS: Doors open to the application of therapeutic drug monitoring in cystic fibrosis treatment

An ultra-high performance liquid chromatography-tandem mass spectrometry method was developed to quantify the cystic fibrosis transmembrane conductance regulator (CFTR) modulators ivacaftor, tezacaftor, elexacaftor, and lumacaftor and their active metabolites hydroxymethyl ivacaftor, tezacaftor M1,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Vol. 1258; p. 124604
Main Authors: Wessels, A. Mireille A., Elzinga, Femke A., Koppelman, Gerard H., Akkerman, Onno W., Mian, Paola, Touw, Daan J.
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 15.05.2025
Subjects:
FDA
CF
IS
QC
CV
IVA
EMA
PK
ISSN:1570-0232, 1873-376X, 1873-376X
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first